A new low-dose estrogen oral contraceptive combination: Effect on endocrine parameters and lipid status
- 1 November 1987
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 36 (5) , 489-497
- https://doi.org/10.1016/0010-7824(87)90001-1
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- A Health Perspective of Hormonal ContraceptivesActa Obstetricia et Gynecologica Scandinavica, 1986
- Oral contraceptives, lipids and cardiovascular diseaseContraception, 1985
- Effects of progestogens on the cardiovascular systemAmerican Journal of Obstetrics and Gynecology, 1982
- The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteinsAmerican Journal of Obstetrics and Gynecology, 1982
- Progestogens and arterial disease—Evidence from the Royal College of General Practitioners' studyAmerican Journal of Obstetrics and Gynecology, 1982
- Lipid metabolic studies in oophorectomized women. Effects induced by the addition of norethisterone acetate to two different oestrogens on serum individual phospholipids and serum lecithin fatty acid compositionActa Endocrinologica, 1981
- The evidence for the antiatherogenicity of high density lipoprotein in manLipids, 1978
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978
- MORTALITY AMONG WOMEN PARTICIPATING IN THE OXFORD/FAMILY PLANNING ASSOCIATION CONTRACEPTIVE STUDYThe Lancet, 1977
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977